Ex-DeepMind scientist launches AI biotech Latent Labs with $50Mnews2025-02-13T00:01:12+00:00February 13th, 2025|Endpoints News|
Regeneron CSO George Yancopoulos on AI’s hype and potentialnews2025-01-22T12:00:06+00:00January 22nd, 2025|Endpoints News|
Pharma is losing the AI talent war against startups: Analysisnews2025-01-11T14:00:12+00:00January 11th, 2025|Endpoints News|
Exclusive: GV-backed Prudentia launches with $7M to boost pharma dealmakingnews2025-01-08T13:00:09+00:00January 8th, 2025|Endpoints News|
Pfizer extends AI drug discovery pact with PostEra, adding ADCs to dealnews2025-01-07T16:10:10+00:00January 7th, 2025|Endpoints News|
Profluent debuts AI model for CRISPR gene editing designnews2025-01-07T12:00:48+00:00January 7th, 2025|Endpoints News|
Exclusive: AI biotech Iambic snags CFO who helped steer Recursion-Exscientia dealnews2025-01-06T11:30:05+00:00January 6th, 2025|Endpoints News|
Ex-Color Health execs raise $10M to bring AI to pharmanews2024-12-19T12:00:18+00:00December 19th, 2024|Endpoints News|
Exclusive: Insitro finds new ALS drug target in Bristol Myers dealnews2024-12-18T12:00:57+00:00December 18th, 2024|Endpoints News|
Isomorphic Labs CEO Demis Hassabis bets on biotech’s AI futurenews2024-12-12T15:00:00+00:00December 12th, 2024|Endpoints News|
